Screener
CG Oncology CGON Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's net income?
- CG Oncology (CGON) reported net income of -$79.06M in Q2 2026.
- How has CG Oncology's net income changed year-over-year?
- CG Oncology's net income decreased by 90.8% year-over-year, from -$41.43M to -$79.06M.
- What is the long-term trend for CG Oncology's net income?
- Over 2 years (2023 to 2025), CG Oncology's net income has grown at a 82.0% compound annual growth rate (CAGR), from -$48.61M to -$161M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about CG Oncology's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude